Fang Nicole Y, Greiner Timothy C, Weisenburger Dennis D, Chan Wing C, Vose Julie M, Smith Lynette M, Armitage James O, Mayer R Aeryn, Pike Brian L, Collins Francis S, Hacia Joseph G
Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5372-7. doi: 10.1073/pnas.0831102100. Epub 2003 Apr 15.
Mutations have been described in the ataxia telangiectasia mutated (ATM) gene in small numbers of cases of lymphoid neoplasia. However, surveys of the ATM mutation status in lymphoma have been limited due to the large size (62 exons) and complex mutational spectrum of this gene. We have used microarray-based assays with 250,000 oligonucleotides to screen lymphomas from 120 patients for all possible ATM coding and splice junction mutations. The subtypes included were diffuse large B cell, mantle cell, immunoblastic large B cell, follicular, posttransplant lymphoproliferative disorder, and peripheral T cell lymphoma. We found the highest percentage of ATM mutations within the mantle cell (MCL) subtype (43%, 12 of 28 cases), followed by a lower level (10% of cases) in the other subtypes. A frame-shift ATM mutation was found in one peripheral T cell lymphoma patient. In six MCL cases examined, four ATM variants were due to somatic mutation in the tumor cells whereas two others seemed to be germ-line in origin. There was no difference in p53 mutation status in the ATM mutant and wild-type groups of MCL. There was no statistically significant difference in the median overall survival of patients with wild-type vs. mutated ATM in MCL. Additional mutational and functional analyses are needed to determine whether ATM mutations contribute to the development and progression of MCL or are just the consequence of genomic instability in MCL.
在少数淋巴系统肿瘤病例中,已发现共济失调毛细血管扩张症突变(ATM)基因存在突变。然而,由于该基因规模较大(62个外显子)且突变谱复杂,对淋巴瘤中ATM突变状态的调查受到限制。我们使用了包含25万个寡核苷酸的基于微阵列的检测方法,对120例患者的淋巴瘤进行筛查,以寻找所有可能的ATM编码和剪接连接突变。所涵盖的亚型包括弥漫性大B细胞淋巴瘤、套细胞淋巴瘤、免疫母细胞性大B细胞淋巴瘤、滤泡性淋巴瘤、移植后淋巴细胞增殖性疾病以及外周T细胞淋巴瘤。我们发现套细胞淋巴瘤(MCL)亚型中ATM突变的比例最高(43%,28例中有12例),其他亚型的比例较低(10%)。在1例外周T细胞淋巴瘤患者中发现了1个移码型ATM突变。在检测的6例MCL病例中,4个ATM变异是由肿瘤细胞中的体细胞突变引起的,而另外2个似乎源自种系。MCL的ATM突变组和野生型组中p53突变状态没有差异。MCL中ATM野生型与突变型患者的中位总生存期没有统计学上的显著差异。需要进一步进行突变和功能分析,以确定ATM突变是有助于MCL的发生发展,还是仅仅是MCL基因组不稳定的结果。